Global Inactivated Poliovirus Vaccine Market Research Report 2023

Report ID: 1897611 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Inactivated Poliovirus Vaccine Market Overview
    1.1 Product Overview and Scope of Inactivated Poliovirus Vaccine
    1.2 Inactivated Poliovirus Vaccine Segment by Type
        1.2.1 Global Inactivated Poliovirus Vaccine Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Human Diploid Cell
        1.2.3 Monkey Kidney Cell
    1.3 Inactivated Poliovirus Vaccine Segment by Application
        1.3.1 Global Inactivated Poliovirus Vaccine Sales Comparison by Application: (2022-2028)
        1.3.2 Public
        1.3.3 Private
    1.4 Global Inactivated Poliovirus Vaccine Market Size Estimates and Forecasts
        1.4.1 Global Inactivated Poliovirus Vaccine Revenue 2017-2028
        1.4.2 Global Inactivated Poliovirus Vaccine Sales 2017-2028
        1.4.3 Inactivated Poliovirus Vaccine Market Size by Region: 2017 Versus 2021 Versus 2028
2 Inactivated Poliovirus Vaccine Market Competition by Manufacturers
    2.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Inactivated Poliovirus Vaccine Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Inactivated Poliovirus Vaccine Manufacturing Sites, Area Served, Product Type
    2.5 Inactivated Poliovirus Vaccine Market Competitive Situation and Trends
        2.5.1 Inactivated Poliovirus Vaccine Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Inactivated Poliovirus Vaccine Players Market Share by Revenue
        2.5.3 Global Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inactivated Poliovirus Vaccine Retrospective Market Scenario by Region
    3.1 Global Inactivated Poliovirus Vaccine Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Inactivated Poliovirus Vaccine Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Inactivated Poliovirus Vaccine Market Facts & Figures by Country
        3.3.1 North America Inactivated Poliovirus Vaccine Sales by Country
        3.3.2 North America Inactivated Poliovirus Vaccine Revenue by Country
        3.3.3 the United States
        3.3.4 Canada
    3.4 Europe Inactivated Poliovirus Vaccine Market Facts & Figures by Country
        3.4.1 Europe Inactivated Poliovirus Vaccine Sales by Country
        3.4.2 Europe Inactivated Poliovirus Vaccine Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 UK
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Inactivated Poliovirus Vaccine Market Facts & Figures by Region
        3.5.1 Asia Pacific Inactivated Poliovirus Vaccine Sales by Region
        3.5.2 Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Inactivated Poliovirus Vaccine Market Facts & Figures by Country
        3.6.1 Latin America Inactivated Poliovirus Vaccine Sales by Country
        3.6.2 Latin America Inactivated Poliovirus Vaccine Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Inactivated Poliovirus Vaccine Market Facts & Figures by Country
        3.7.1 Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country
        3.7.2 Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Inactivated Poliovirus Vaccine Historic Market Analysis by Type
    4.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2022)
    4.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Type (2017-2022)
    4.3 Global Inactivated Poliovirus Vaccine Price by Type (2017-2022)
5 Global Inactivated Poliovirus Vaccine Historic Market Analysis by Application
    5.1 Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2022)
    5.2 Global Inactivated Poliovirus Vaccine Revenue Market Share by Application (2017-2022)
    5.3 Global Inactivated Poliovirus Vaccine Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Sanofi
        6.1.1 Sanofi Corporation Information
        6.1.2 Sanofi Description and Business Overview
        6.1.3 Sanofi Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Sanofi Inactivated Poliovirus Vaccine Product Portfolio
        6.1.5 Sanofi Recent Developments/Updates
    6.2 GSK
        6.2.1 GSK Corporation Information
        6.2.2 GSK Description and Business Overview
        6.2.3 GSK Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 GSK Inactivated Poliovirus Vaccine Product Portfolio
        6.2.5 GSK Recent Developments/Updates
    6.3 Serum Institute (Bilthoven Biologicals)
        6.3.1 Serum Institute (Bilthoven Biologicals) Corporation Information
        6.3.2 Serum Institute (Bilthoven Biologicals) Description and Business Overview
        6.3.3 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product Portfolio
        6.3.5 Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
    6.4 IMBCA
        6.4.1 IMBCA Corporation Information
        6.4.2 IMBCA Description and Business Overview
        6.4.3 IMBCA Inactivated Poliovirus Vaccine Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 IMBCA Inactivated Poliovirus Vaccine Product Portfolio
        6.4.5 IMBCA Recent Developments/Updates
7 Inactivated Poliovirus Vaccine Manufacturing Cost Analysis
    7.1 Inactivated Poliovirus Vaccine Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Inactivated Poliovirus Vaccine
    7.4 Inactivated Poliovirus Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Inactivated Poliovirus Vaccine Distributors List
    8.3 Inactivated Poliovirus Vaccine Customers
9 Inactivated Poliovirus Vaccine Market Dynamics
    9.1 Inactivated Poliovirus Vaccine Industry Trends
    9.2 Inactivated Poliovirus Vaccine Market Drivers
    9.3 Inactivated Poliovirus Vaccine Market Challenges
    9.4 Inactivated Poliovirus Vaccine Market Restraints
10 Global Market Forecast
    10.1 Inactivated Poliovirus Vaccine Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Inactivated Poliovirus Vaccine by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Inactivated Poliovirus Vaccine by Type (2023-2028)
    10.2 Inactivated Poliovirus Vaccine Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Inactivated Poliovirus Vaccine by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Inactivated Poliovirus Vaccine by Application (2023-2028)
    10.3 Inactivated Poliovirus Vaccine Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Inactivated Poliovirus Vaccine by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Inactivated Poliovirus Vaccine by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Inactivated Poliovirus Vaccine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Inactivated Poliovirus Vaccine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Inactivated Poliovirus Vaccine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Inactivated Poliovirus Vaccine Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Inactivated Poliovirus Vaccine Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Inactivated Poliovirus Vaccine Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Inactivated Poliovirus Vaccine Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Inactivated Poliovirus Vaccine Average Price (USD/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Inactivated Poliovirus Vaccine Manufacturing Sites and Area Served
    Table 11. Manufacturers Inactivated Poliovirus Vaccine Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Inactivated Poliovirus Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inactivated Poliovirus Vaccine as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Inactivated Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
    Table 16. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2022)
    Table 17. Global Inactivated Poliovirus Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2017-2022)
    Table 19. North America Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
    Table 20. North America Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2022)
    Table 21. North America Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2022)
    Table 23. Europe Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2022)
    Table 25. Europe Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Inactivated Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Inactivated Poliovirus Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Inactivated Poliovirus Vaccine Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2022)
    Table 33. Latin America Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Inactivated Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Inactivated Poliovirus Vaccine Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Inactivated Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Inactivated Poliovirus Vaccine Revenue Market Share by Country (2017-2022)
    Table 39. Global Inactivated Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
    Table 40. Global Inactivated Poliovirus Vaccine Sales Market Share by Type (2017-2022)
    Table 41. Global Inactivated Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Inactivated Poliovirus Vaccine Revenue Share by Type (2017-2022)
    Table 43. Global Inactivated Poliovirus Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 44. Global Inactivated Poliovirus Vaccine Sales (K Units) by Application (2017-2022)
    Table 45. Global Inactivated Poliovirus Vaccine Sales Market Share by Application (2017-2022)
    Table 46. Global Inactivated Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Inactivated Poliovirus Vaccine Revenue Share by Application (2017-2022)
    Table 48. Global Inactivated Poliovirus Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 49. Sanofi Corporation Information
    Table 50. Sanofi Description and Business Overview
    Table 51. Sanofi Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 52. Sanofi Inactivated Poliovirus Vaccine Product
    Table 53. Sanofi Recent Developments/Updates
    Table 54. GSK Corporation Information
    Table 55. GSK Description and Business Overview
    Table 56. GSK Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 57. GSK Inactivated Poliovirus Vaccine Product
    Table 58. GSK Recent Developments/Updates
    Table 59. Serum Institute (Bilthoven Biologicals) Corporation Information
    Table 60. Serum Institute (Bilthoven Biologicals) Description and Business Overview
    Table 61. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 62. Serum Institute (Bilthoven Biologicals) Inactivated Poliovirus Vaccine Product
    Table 63. Serum Institute (Bilthoven Biologicals) Recent Developments/Updates
    Table 64. IMBCA Corporation Information
    Table 65. IMBCA Description and Business Overview
    Table 66. IMBCA Inactivated Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 67. IMBCA Inactivated Poliovirus Vaccine Product
    Table 68. IMBCA Recent Developments/Updates
    Table 69. Production Base and Market Concentration Rate of Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Inactivated Poliovirus Vaccine Distributors List
    Table 72. Inactivated Poliovirus Vaccine Customers List
    Table 73. Inactivated Poliovirus Vaccine Market Trends
    Table 74. Inactivated Poliovirus Vaccine Market Drivers
    Table 75. Inactivated Poliovirus Vaccine Market Challenges
    Table 76. Inactivated Poliovirus Vaccine Market Restraints
    Table 77. Global Inactivated Poliovirus Vaccine Sales Forecast by Type (2023-2028) & (K Units)
    Table 78. Global Inactivated Poliovirus Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 79. Global Inactivated Poliovirus Vaccine Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 80. Global Inactivated Poliovirus Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 81. Global Inactivated Poliovirus Vaccine Sales Forecast by Application (2023-2028) & (K Units)
    Table 82. Global Inactivated Poliovirus Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 83. Global Inactivated Poliovirus Vaccine Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 84. Global Inactivated Poliovirus Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 85. Global Inactivated Poliovirus Vaccine Sales Forecast by Region (2023-2028) & (K Units)
    Table 86. Global Inactivated Poliovirus Vaccine Sales Market Share Forecast by Region (2023-2028)
    Table 87. Global Inactivated Poliovirus Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 88. Global Inactivated Poliovirus Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 89. Research Programs/Design for This Report
    Table 90. Key Data Information from Secondary Sources
    Table 91. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Inactivated Poliovirus Vaccine
    Figure 2. Global Inactivated Poliovirus Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Human Diploid Cell Product Picture
    Figure 4. Monkey Kidney Cell Product Picture
    Figure 5. Global Inactivated Poliovirus Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Public
    Figure 7. Private
    Figure 8. Global Inactivated Poliovirus Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 9. Global Inactivated Poliovirus Vaccine Market Size (2017-2028) & (US$ Million)
    Figure 10. Global Inactivated Poliovirus Vaccine Sales (2017-2028) & (K Units)
    Figure 11. Inactivated Poliovirus Vaccine Sales Share by Manufacturers in 2021
    Figure 12. Global Inactivated Poliovirus Vaccine Revenue Share by Manufacturers in 2021
    Figure 13. The Global 5 and 10 Largest Inactivated Poliovirus Vaccine Players: Market Share by Revenue in 2021
    Figure 14. Inactivated Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 15. Global Inactivated Poliovirus Vaccine Sales Market Share by Region (2017-2022)
    Figure 16. Global Inactivated Poliovirus Vaccine Sales Market Share by Region in 2021
    Figure 17. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region (2017-2022)
    Figure 18. Global Inactivated Poliovirus Vaccine Revenue Market Share by Region in 2021
    Figure 19. the United States Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 20. Canada Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 21. Germany Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. France Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. UK Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Italy Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Russia Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. China Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Japan Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. South Korea Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. India Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. Australia Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. China Taiwan Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Indonesia Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. Thailand Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Malaysia Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Mexico Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Brazil Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Argentina Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Turkey Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Saudi Arabia Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. UAE Inactivated Poliovirus Vaccine Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Sales Market Share of Inactivated Poliovirus Vaccine by Type (2017-2022)
    Figure 42. Manufacturing Cost Structure of Inactivated Poliovirus Vaccine
    Figure 43. Manufacturing Process Analysis of Inactivated Poliovirus Vaccine
    Figure 44. Inactivated Poliovirus Vaccine Industrial Chain Analysis
    Figure 45. Channels of Distribution
    Figure 46. Distributors Profiles
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
GSK
Serum Institute (Bilthoven Biologicals)
IMBCA
Frequently Asked Questions
Inactivated Poliovirus Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Inactivated Poliovirus Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Inactivated Poliovirus Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports